← Eichor
Study identifier: NCT03675386 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Reducing Opioid Use for Chronic Pain Patients Following Surgery

Condition: Chronic Pain · Opioid Use · Postoperative Pain  ·  Sponsor: University Health Network, Toronto

PhaseNA
Planned participants210
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.

This description comes directly from the study's public registry record.

Talk to the study team

Karim Ladha, MD  ·  416-719-0030  ·  Karim.Ladha@uhn.ca

Hance Clarke, MD, PhD  ·  416-340-4800  ·  Hance.Clarke@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Toronto General Hospital- University Health NetworkToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03675386